Online citations, reference lists, and bibliographies.
← Back to Search

Dissolution Profiles Of Flurbiprofen In Phospholipid Solid Dispersions.

M. Habib, M. Phan, G. Owusu-Ababio
Published 1998 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This study is concerned with the development of a solid dispersion formulation of flurbiprofen (FLP) and phospholipid (PL) with improved dissolution characteristics. The FLP powders were blended with PL to produce FLP-PL physical mixtures or made into solid dispersions with PL by the solvent method. The FLP exhibited significantly improved dissolution rates in PL coprecipitate (coppt) compared to the physical mixtures or FLP alone. The dissolution studies suggested that less than a 20:1 ratio of FLP to PL was required to disperse FLP completely in the carrier. The coppt yielded a ninefold greater initial dissolution rate. Also, the total amount dissolved after 60 min was twofold greater at a 10:1 ratio of FLP to L-(-dimyristoyl phosphatidylglycerol (DMPG). Similar results were observed with a ratio as low as 20:1 (FLP:DMPG). Increasing the DMPG content did not increase the rate to any significant extent. Thus, a small PL:FLP ratio improved the dissolution to a significant level. Thus, an FLP:PL dispersion may have the clinical advantages of quick release and excellent bioavailability.
This paper references



This paper is referenced by
10.3109/03639045.2012.760578
Vesicles composed of fatty acid and N-[3-(dimethylamino)propyl]-octadecanamide: effect of fatty acid chain length on physicochemical properties of vesicles
M. H. Wang (2014)
10.3329/DUJPS.V11I2.14558
Preparation and in vitro Evaluation of Inclusion Complexes of Nelfinavir with Chemically Modified β-cyclodextrins
S. Hiremath (2013)
IMPROVEMENT OF DISSOLUTION CHARACTERISTICS AND BIOAVAILABILITY OF TADALAFIL BY SOLID DISPERSION TECHNIQUE USING WATER-SOLUBLE POLYMERS
V. Kumar (2012)
10.1016/j.ejps.2015.08.005
Phospholipid-based solid drug formulations for oral bioavailability enhancement: A meta-analysis.
Sophia Yui Kau Fong (2015)
10.3109/10717544.2010.509365
Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change
D. Oh (2011)
10.3109/10837450903110745
The effect of physico-chemical properties of the drug on the pharmaceutical availability of piroxicam from pellets
B. Pieszczek (2010)
10.3109/02652048.2013.774447
Flurbiprofen-loaded nanoparticles prepared with polyvinylpyrrolidone using Shirasu porous glass membranes and a spray-drying technique: nano-sized formation and improved bioavailability
D. Oh (2013)
10.1007/s12272-010-2231-9
Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound
D. X. Li (2010)
Greenwich Academic Literature Archive (GALA)
K. Tomlins (2010)
10.3109/02652048.2011.651497
Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier
D. W. Kim (2012)
10.1016/S0378-5173(01)00621-4
Bioavailability of cyclosporin A dispersed in sodium lauryl sulfate-dextrin based solid microspheres.
E. Lee (2001)
A comparison of gastrointestinal permeability induced by diclofenac-phospholipid complex with diclofenac acid and its sodium salt.
T. Khazaeinia (2003)
10.1007/S10847-009-9560-7
Thermo-reversible flurbiprofen liquid suppository with HP-β-CD as a solubility enhancer: improvement of rectal bioavailability
Jin-Ki Kim (2009)
10.1016/j.ejpb.2016.04.024
Solid-state flurbiprofen and methyl-β-cyclodextrin inclusion complexes prepared using a single-step, organic solvent-free supercritical fluid process.
Shashi Ravi Suman Rudrangi (2016)
10.1016/j.jpba.2008.11.003
Physical-chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids.
M. Cirri (2009)
10.1002/JPS.20754
Factors affecting the formation of eutectic solid dispersions and their dissolution behavior.
Sudha Vippagunta (2007)
10.2165/00137696-200402020-00004
Solubility enhancers for oral drug delivery
C. Kim (2004)
10.1016/j.ejpb.2008.06.024
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
S. M. Badr-Eldin (2008)
10.1007/s12272-011-0306-x
Enhanced solubility and bioavailability of flurbiprofen by cycloamylose
H. Baek (2011)
10.25073/2588-1132/VNUMPS.4259
Preparation and Characterization of Flurbiprofen/β-Cyclodextrin Inclusion Complex
Nguyễn Thị Thanh Bình (2020)
Semantic Scholar Logo Some data provided by SemanticScholar